Dr. Ghazala T Farooqui MD

Recommended Articles

• New, Promising Cystic Fibrosis Drug Needs Funding

  Canada has the highest rate of cystic fibrosis in the entire world, with approximately 1 in 134 citizens suffering from the disease. However, a recent drug that has been found to be "life changing" for some cystic fibrosis patients is not being funded.Official responseHealth Minister Adrian Dix...

• Bronchiolitis – Signs, Symptoms, and Treatment

  What is Bronchiolitis?Bronchiolitis is a viral infection of the respiratory system, usually affecting the smallest air passages known as the bronchioles. Bronchioles are part of the lungs that control the airflow in and out of the lungs. When these bronchioles become infected, they tend to swell and...

• Does the Treatment of Asthma Always Require an Inhaler?

  Asthma is considered a common lung disorder in which inflammation causes the bronchi to swell and narrow the airways. Asthma is indiscriminant of any age group. It is a long term disease that has no cure but can be controlled by following the right dosage of medication, prescribed by a doctor or...

• Pneumonia in an Immunocompromised Patient

  Pneumonia as a disease was once dreaded, since most of the cases would turn out to be fatal. This was many years ago, and with medical advances, times have changed. However, in some severe cases of pneumonia, especially in people with weakened immune systems, the disease can still be fatal. If the...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...

• What a Lung Transplantation for Cystic Fibrosis Is Really Like

  Cystic fibrosis has been one of the more devastating and debilitating diseases to take hold of the population. The condition has forced countless research studies, clinical trials, and innovative treatments to try and mitigate the symptoms and effects of cystic fibrosis. One of the riskier but...